Table 3. Changes in transfusion... | American Society of Hematology

Table 3.

Changes in transfusion requirements during eculizumab treatment

	Transfusion rates
	Before study^*			12 wk			64 wk
Patient group	Mean	Median	Mean	Median	Mean	Median	P†
All patients	2.1	1.8	0.6	0.0	0.5	0.3	.001
Patients without cytopenia‡	2.4	2.0	0.2	0.0	0.2	0.1	-
Patients with cytopenia§	1.8	1.8	1.2	0.7	0.8	0.7	-

	Transfusion rates
	Before study^*			12 wk			64 wk
Patient group	Mean	Median	Mean	Median	Mean	Median	P†
All patients	2.1	1.8	0.6	0.0	0.5	0.3	.001
Patients without cytopenia‡	2.4	2.0	0.2	0.0	0.2	0.1	-
Patients with cytopenia§	1.8	1.8	1.2	0.7	0.8	0.7	-

Transfusion rates are units per patient per month.

- indicates not determined.

Values during 52-week period before treatment.

Comparisons of median change from before study to the 64-week treatment period.

Platelet count ≥ 150 × 10⁹/L; n = 6.

Platelet count < 150 × 10⁹/L; n = 5.